Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.zacks.com › stock › quoteIntellia Therapeutics - NTLA - Stock Price Today - Zacks

   www.zacks.com › stock › quote

   • Zapisane w pamięci cache

   6 dni temu · Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

2. finance.yahoo.com › quote › NTLAIntellia Therapeutics, Inc. (NTLA) - Yahoo Finance

   finance.yahoo.com › quote › NTLA

   • Zapisane w pamięci cache

   Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing.

3. www.marketwatch.com › investing › stockNTLA Stock Price | Intellia Therapeutics Inc. Stock Quote (U.S.:...

   www.marketwatch.com › investing › stock

   15 lis 2024 · NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

4. www.nasdaq.com › articles › is-it-a-good-idea-to-invest-in-intellia-ntla-stock-nowIs it a Good Idea to Invest in Intellia (NTLA) Stock Now?

   www.nasdaq.com › articles › is-it-a-good-idea-to-invest-in-intellia-ntla-stock-now

   • Zapisane w pamięci cache

   18 sty 2024 · Intellia currently carries a Zacks Rank #2 (Buy). Some other top-ranked stocks in the healthcare sector are CytomX Therapeutics, Inc. CTMX and Puma Biotechnology, Inc. PBYI, each sporting a...

5. www.nasdaq.com › articles › all-you-need-know-about-intellia-therapeutics-ntlaAll You Need to Know About Intellia Therapeutics (NTLA) Rating...

   www.nasdaq.com › articles › all-you-need-know-about-intellia-therapeutics-ntla

   • Zapisane w pamięci cache

   11 lip 2024 · Intellia Therapeutics, Inc. (NTLA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in...

6. finance.yahoo.com › news › why-intellia-therapeutics-inc-ntla-221503993Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market...

   finance.yahoo.com › news › why-intellia-therapeutics-inc-ntla-221503993

   • Zapisane w pamięci cache

   3 maj 2024 · Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$5.57 per share and revenue of $50.96 million, indicating changes of -2.77% and +40.49%, respectively, compared to...

7. finviz.com › quoteNTLA - Intellia Therapeutics Inc Stock Price and Quote -...

   finviz.com › quote

   • Zapisane w pamięci cache

   (Zacks) Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system.